EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Investigating the effects of orexin receptor 1 antagonism on decision making under uncertainty

Jeremy A Metha, Mathilde Bertheau, Carsten Murawski, Daniel Hoyer, Laura H Jacobson

Behavioural Brain Research · 2025

DOI: 10.1016/j.bbr.2025.115691 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Behavioural Brain Research, 2025. Verfasst von Jeremy A Metha und 4 weiteren Autor:innen. Beteiligte Einrichtung: Sleep and Cognition, Florey Institute of Neuroscience and Mental Health, Parkville, VIC, Australia; Centre for Brain, Mind and Markets, The Universit…. Hauptthemen laut MEDLINE: Orexin Receptor Antagonists, Decision Making, Orexin Receptors. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: State Government of Victoria, Florey Institute of Neuroscience and Mental Health, National Health and Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Orexins/hypocretins are neuropeptides produced by several thousand neurons in the lateral hypothalamus. They project widely through the central nervous system where they release orexins which bind to two regionally selective G-protein coupled receptors: OX1R and OX2R. Orexins are well known as regulators of the sleep/wake cycle, however, recent investigations into orexinergic modulation of feeding and drug-seeking behaviour suggest they also play a role in reward processing and decision making. In the present study, we investigated the effects of OX1R antagonism on goal-directed decision making using an operant probabilistic reversal learning (PRL) task. 44 male C57/BL6 mice were dosed daily with an OX1R selective antagonist (1-SORA-51, 45 mg/kg) or vehicle (20 % w/v TPGS) while performing a PRL task consisting of 5 sessions on 5 consecutive days of probabilistic discrimination learning, followed by 5 sessions of reversal learning, both on and off drug, in a crossover design. Behaviours were then analysed within a reinforcement learning framework. Mice treated with 1-SORA-51 show a significant decrease in learning both initial and reversed reward contingencies, mediated largely through learning from positive outcomes. 1-SORA-51 also increased exploratory behaviours, both during learning and after reward contingencies had been learned. The findings suggest that OX1R signalling plays multiple roles in decision making in both learning and reward processing, largely by impacting the positive reward domain. As such, OX1R antagonists may be of therapeutic interest for improving abnormal reward processing and explore-exploit behaviours, such as the heightened sensitivity to drug cues and reduced responses to natural rewards, or heightened delay discounting as observed in people with substance use disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Orexin Receptor AntagonistsDecision MakingOrexin ReceptorsAnimalsMaleMice, Inbred C57BLConditioning, OperantMiceReversal LearningRewardProbability Learning

Stichwörter der Autor:innen

Decision makingHypocretinMiceOrexinOrexin 1 receptor antagonistRewardUncertainty

Substanzen

Orexin Receptor AntagonistsOrexin Receptors

Autor:innen und Institutionen

  • Sleep and Cognition, Florey Institute of Neuroscience and Mental Health, Parkville, VIC, Australia; Centre for Brain, Mind and Markets, The University of Melbourne, Melbourne, VIC, Australia; Translational Pharmacology,…
  • Sleep and Cognition, Florey Institute of Neuroscience and Mental Health, Parkville, VIC, Australia; École publique d'ingénieurs de la santé et du numérique (EPISEN), IDF, Paris, France.
  • Centre for Brain, Mind and Markets, The University of Melbourne, Melbourne, VIC, Australia.
  • Sleep and Cognition, Florey Institute of Neuroscience and Mental Health, Parkville, VIC, Australia; Translational Pharmacology, Dept. Biochemistry & Pharmacology, The University of Melbourne, Parkville, VIC, Australia;…
  • Sleep and Cognition, Florey Institute of Neuroscience and Mental Health, Parkville, VIC, Australia; Translational Pharmacology, Dept. Biochemistry & Pharmacology, The University of Melbourne, Parkville, VIC, Australia.…

Förderung

  • State Government of Victoria
  • Florey Institute of Neuroscience and Mental Health
  • National Health and Medical Research Council
  • Merck
  • Faculty of Business and Economics, University of Melbourne
  • University of Melbourne

Zitieren

APA

Metha, J. A., Bertheau, M., Murawski, C., Hoyer, D., & Jacobson, L. H. (2025). Investigating the effects of orexin receptor 1 antagonism on decision making under uncertainty. Behavioural Brain Research. https://doi.org/10.1016/j.bbr.2025.115691

Vancouver

Metha JA, Bertheau M, Murawski C, Hoyer D, Jacobson LH. Investigating the effects of orexin receptor 1 antagonism on decision making under uncertainty. Behavioural Brain Research. 2025. doi:10.1016/j.bbr.2025.115691

BibTeX
@article{Metha2025,
  author = {Metha, Jeremy A and Bertheau, Mathilde and Murawski, Carsten and Hoyer, Daniel and Jacobson, Laura H},
  title = {Investigating the effects of orexin receptor 1 antagonism on decision making under uncertainty},
  journal = {Behavioural Brain Research},
  year = {2025},
  doi = {10.1016/j.bbr.2025.115691}
}
Kostenlos starten →